
Bionl.ai helps scientists and researchers automate routine data and workflow tasks in biomedical research using natural language. It is a no-code bioinformatics pipeline management platform that uses generative AI to let users query, run, and manage analyses with conversational commands. The platform automates cloud and file system orchestration, data management, and workflow execution for common bioinformatics tools and pipelines. Bionl.ai operates as a B2B SaaS product for research labs, biotech teams, and academic groups working in biomedical and genomic research.

Bionl.ai helps scientists and researchers automate routine data and workflow tasks in biomedical research using natural language. It is a no-code bioinformatics pipeline management platform that uses generative AI to let users query, run, and manage analyses with conversational commands. The platform automates cloud and file system orchestration, data management, and workflow execution for common bioinformatics tools and pipelines. Bionl.ai operates as a B2B SaaS product for research labs, biotech teams, and academic groups working in biomedical and genomic research.
Headquarters: Boston, Massachusetts
Product: No-code bioinformatics / biomedical research platform with generative-AI assistant and pipeline management
Founded: 2022
Stage / Funding: Seed; $2,080,000 total disclosed
Founder / CEO: Ahmad Jadallah
Bioinformatics workflow automation and clinical genomics pipeline management for biomedical research and diagnostic labs.
2022
Biotechnology
2080000
“Alchemist Accelerator; Propeller Inc.”